Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Clinical Trial of 4 Months of Rifampin vs. 9 Months of Isoniazid for Latent Tuberculosis Infection. Part 3 - Effectiveness

NCT00931736 is registered in ClinicalTrials.gov with McGill University as lead sponsor.

NCT NCT00931736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00931736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Clinical Trial of 4 Months of Rifampin vs. 9 Months of Isoniazid for Latent Tuberculosis Infection. Part 3 - Effectiveness
Lead sponsor
McGill University
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2009
Completion date
April 30, 2017
Enrollment
6,031 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

latent tuberculosis infection